Additionally, secondary endpoints showed an 18% reduction in the risk of major cardiovascular events and a 20% reduction in the risk of death from any cause
Dailey MJ, Moran TH: Glucagon-like peptide 1 and appetite
This approach encourages personalized, evidence-based care rather than cost-driven decisions about your treatment
Requirements include ~60 hours of obesity-specific CME covering nutrition, exercise physiology, behavioral interventions, pharmacotherapy, and metabolic science, plus passing a comprehensive exam
An evaluation of the impact of Adriamycin on metabolic pathways was performed based on a tool for metabolomic data analysis available online
Plaintiffs in the Ozempic lawsuit allege that the manufacturer failed to adequately disclose these severe risks to patients and healthcare providers